The observation that tumors developing in TRAIL−/− but not in wild-type mice retained TRAIL-sensitivity [289] indicates that tumor cells can develop mechanisms to avoid TRAIL-mediated killing [1,2]. The gene discussed is TNFSF10; the disease is neoplasm.